However, data comparing Gal-3 predictive value to established biomarkers for HF are conflicting, suggesting that Gal-3 has major prognostic efficacy when used in combination with other HF biomarkers than alone (101). The gene discussed is LGALS3; the disease is hydrops fetalis.